Andrew Patterson, MD
Dermatology · la Vista, NENPI 1578954731
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,722 of the $2,102 with a category attached, or 81.9%. 21 manufacturers reported payments, led by Johnson & Johnson at 25.0% of the total. 2025 is the largest year on record at $749, 6.0 times the $125 reported in 2020. That places this record below the midpoint for dermatology clinicians in NE, where the typical reported total is $2,089.
Across 117 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$525
- Teladoc Health, Inc.$300
- Lilly USA, LLC$220
- Sanofi$159
- Genentech USA, Inc.$125
- Sanofi-aventis U.S. LLC$116
- plus $657 from 15 others
What the payments were for
- Speaking & faculty fees$30014%
- Food & beverage$1,72282%
- Education$804%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 47 | $525 |
| Teladoc Health, Inc. | 1 | $300 |
| Lilly USA, LLC | 19 | $220 |
| Sanofi | 10 | $159 |
| Genentech USA, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 3 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 4 | $75 |
| Bayer | 5 | $69 |
| Pfizer | 4 | $68 |
| Organon | 3 | $60 |
| LEO Pharma Inc. | 2 | $54 |
| Novo Nordisk | 3 | $51 |
| AbbVie | 2 | $49 |
| Boehringer Ingelheim | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erivedge$125
How this compares
$2,102 in reported general payments places this provider in the 50th percentile of 68 dermatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 42 | $170,377 |
| Taltz AutoinjectorIxekizumab | 11 | $76,462 |
| Doxycycline Monohydrate | 121 | $8,638 |
| Clobetasol Propionate | 87 | $5,092 |
| Tacrolimus | 45 | $3,695 |
| Pimecrolimus | 23 | $3,286 |
| Triamcinolone Acetonide | 193 | $3,030 |
| Fluconazole | 76 | $2,896 |
| Doxycycline Hyclate | 59 | $2,610 |
| Azelaic Acid | 16 | $2,042 |
| Ketoconazole | 115 | $1,731 |
| Metronidazole | 32 | $1,230 |
| Fluorouracil | 13 | $1,165 |
| Clindamycin Phosphate | 12 | $634 |
| Mupirocin | 32 | $388 |
Paid to pharmacies, not to this prescriber.
Other dermatology in la Vista
- Rachel PersonOmaha$98K
- Erin BarrettOmaha$96K
- Joel SchlessingerOmaha$89K
- Casey BowenLincoln$51K
- Mathew DaveyOmaha$35K
- Rex LargenLincoln$26K
- Lauren StephensLincoln$18K
- Chad HillyerElkhorn$15K
- Gage RenschOmaha$11K
- Gina WeirLincoln$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.